What if I told you a company had developed a vaccine for a terrible disease? The news would be fantastic for that company’s stock. But what if the same company offered a vaccine for a disease that had essentially been cured? The market would likely yawn.
Tax-managed equity funds offer low to zero capital gain distributions to address a pervasive problem: the corrosive impact of capital gain distributions from many mutual funds. But low to zero capital gain distributions are likely only beneficial if the after-tax performance…
Read the full article here